Lung weight parallels disease severity in experimental coccidioidomycosis.
Evidence provided by histopathological study of lesions is a valuable adjunct for evaluating chemotherapeutic efficacy in experimental animal models, In addition, this should be correlated with a measure of disease severity in the same animal. The latter could be obtained by homogenization of infected organs and quantitative enumeration of viable cells of the etiological agent, but this would preclude histopathological studies in the same animal. Progression of disease in pulmonary infection is associated with replacement of air space by fluid, cells, and cellular debris. Therefore, an increase in lung weight should reflect severity of disease. Results with the murine model of coccidioidomycosis demonstrate that increasing lung weight parallels the increasing census of fungus cells in the lungs of both treated and nontreated infected mice. This was supported with evidence obtained from microscopic studies of lesions indicating that specific chemotherapy limited spread of the infection and inhibited multiplication of the fungus in the lung. Therefore, lung weight can be used as a measure of disease severity in the murine model of coccidioidomycosis.
D000666:Amphotericin B / Q000627:therapeutic use; D000818:Animals; D001996:Bronchopneumonia / Q000473:pathology; D003045:Coccidioides / Q000254:growth & development; D003047:Coccidioidomycosis / Q000188:drug therapy / Q000382:microbiology* / Q000401:mortality; D008168:Lung / Q000033:anatomy & histology*; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA; D009504:Neutrophils / Q000382:microbiology; D009929:Organ Size
D000666:Amphotericin B